{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:23Z","timestamp":1792783343815,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Chinese PLA military family planning project","award":["22JSZ16"],"award-info":[{"award-number":["22JSZ16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02936-y","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:01:30Z","timestamp":1750284090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Publication trends and hotspots for cervical cancer screening biomarker: a bibliometric analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanguang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"3","key":"2936_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2936_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","volume":"8","author":"SL Bedell","year":"2020","unstructured":"Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28\u201337.","journal-title":"Sex Med Rev"},{"issue":"4","key":"2936_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/ijgc-2020-001285","volume":"30","author":"M Gultekin","year":"2020","unstructured":"Gultekin M, Ramirez PT, Broutet N, Hutubessy R. World health organization call for action to eliminate cervical cancer globally. Int J Gynecol Cancer. 2020;30(4):426\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"20","key":"2936_CR4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","volume":"385","author":"V Bouvard","year":"2021","unstructured":"Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, et al. The IARC perspective on cervical Cancer screening. N Engl J Med. 2021;385(20):1908\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"2936_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ygyno.2020.07.099","volume":"159","author":"H Bao","year":"2020","unstructured":"Bao H, Bi H, Zhang X, Zhao Y, Dong Y, Luo X, Zhou D, You Z, Wu Y, Liu Z, et al. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study. Gynecol Oncol. 2020;159(1):171\u20138.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2936_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","volume":"26","author":"PJ Maver","year":"2020","unstructured":"Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26(5):579\u201383.","journal-title":"Clin Microbiol Infect"},{"issue":"28","key":"2936_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23280","volume":"23","author":"C Gilham","year":"2019","unstructured":"Gilham C, Sargent A, Kitchener HC, Peto J. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Health Technol Assess. 2019;23(28):1\u201344.","journal-title":"Health Technol Assess"},{"key":"2936_CR8","doi-asserted-by":"crossref","unstructured":"Volkova LV, Pashov AI, Omelchuk NN. Cervical carcinoma: oncobiology and biomarkers. Int J Mol Sci 2021, 22(22).","DOI":"10.3390\/ijms222212571"},{"issue":"6","key":"2936_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/phar.1586","volume":"35","author":"DF Thompson","year":"2015","unstructured":"Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy. 2015;35(6):551\u20139.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2936_CR10","doi-asserted-by":"publisher","first-page":"e0261503","DOI":"10.1371\/journal.pone.0261503","volume":"17","author":"D Bruggmann","year":"2022","unstructured":"Bruggmann D, Quinkert-Schmolke K, Jaque JM, Quarcoo D, Bohlmann MK, Klingelhofer D, Groneberg DA. Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis. PLoS ONE. 2022;17(1):e0261503.","journal-title":"PLoS ONE"},{"issue":"4","key":"2936_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetrics. 2017;11(4):959\u201375.","journal-title":"J Informetrics"},{"issue":"10","key":"2936_CR12","doi-asserted-by":"publisher","first-page":"e0223994","DOI":"10.1371\/journal.pone.0223994","volume":"14","author":"C Chen","year":"2019","unstructured":"Chen C, Song M. Visualizing a field of research: A methodology of systematic scientometric reviews. PLoS ONE. 2019;14(10):e0223994.","journal-title":"PLoS ONE"},{"issue":"6","key":"2936_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1634\/theoncologist.2014-0303","volume":"20","author":"B Wang","year":"2015","unstructured":"Wang B, He M, Chao A, Engelgau MM, Saraiya M, Wang L, Wang L. Cervical Cancer screening among adult women in china, 2010. Oncologist. 2015;20(6):627\u201334.","journal-title":"Oncologist"},{"issue":"3","key":"2936_CR14","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.3802\/jgo.2020.31.e55","volume":"31","author":"ES Aoki","year":"2020","unstructured":"Aoki ES, Yin R, Li K, Bhatla N, Singhal S, Ocviyanti D, Saika K, Suh M, Kim M, Termrungruanglert W. National screening programs for cervical cancer in Asian countries. J Gynecol Oncol. 2020;31(3):e55.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2936_CR15","doi-asserted-by":"publisher","first-page":"20821","DOI":"10.1038\/s41598-023-48220-3","volume":"13","author":"BK Mishra","year":"2023","unstructured":"Mishra BK, Mohanty SN, Baidyanath RR, Ali S, Abduvalieva D, Awwad FA, Ismail EAA, Gupta M. An efficient framework for obtaining the initial cluster centers. Sci Rep. 2023;13(1):20821.","journal-title":"Sci Rep"},{"issue":"5","key":"2936_CR16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","volume":"24","author":"YY Kan","year":"2014","unstructured":"Kan YY, Liou YL, Wang HJ, Chen CY, Sung LC, Chang CF, Liao CI. PAX1 methylation as a potential biomarker for cervical cancer screening. Int J Gynecol Cancer. 2014;24(5):928\u201334.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"2936_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/ijc.28790","volume":"135","author":"AR Brentnall","year":"2014","unstructured":"Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes. Int J Cancer. 2014;135(6):1425\u201332.","journal-title":"Int J Cancer"},{"issue":"5","key":"2936_CR18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/jog.12322","volume":"40","author":"X Zhang","year":"2014","unstructured":"Zhang X, Ma Y, Wu Y, Lin L, Ma X, Zhang Y. Aberrant promoter methylation and Silencing of RASSF2A gene in cervical cancer. J Obstet Gynaecol Res. 2014;40(5):1375\u201381.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2936_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12889-024-17842-1","volume":"24","author":"F Mantula","year":"2024","unstructured":"Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in africa: a systematic review. BMC Public Health. 2024;24(1):525.","journal-title":"BMC Public Health"},{"key":"2936_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2021.10.036","volume":"525","author":"S Zhao","year":"2022","unstructured":"Zhao S, Huang L, Basu P, Domingo EJ, Supakarapongkul W, Ling WY, Ocviyanti D, Rezhake R, Qiao Y, Tay EH, et al. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in association of Southeast Asian nations (ASEAN) countries. Cancer Lett. 2022;525:22\u201332.","journal-title":"Cancer Lett"},{"issue":"8","key":"2936_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130(8):1715\u201325.","journal-title":"Int J Cancer"},{"issue":"15","key":"2936_CR22","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.4161\/cc.10.15.16776","volume":"10","author":"AK Witkiewicz","year":"2011","unstructured":"Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle. 2011;10(15):2497\u2013503.","journal-title":"Cell Cycle"},{"issue":"2","key":"2936_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix Uteri. Int J Cancer. 2001;92(2):276\u201384.","journal-title":"Int J Cancer"},{"issue":"15","key":"2936_CR24","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","volume":"18","author":"N Wentzensen","year":"2012","unstructured":"Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, et al. Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154\u201362.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2936_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ijc.33812","volume":"150","author":"TC Wright Jr","year":"2022","unstructured":"Wright TC Jr., Stoler MH, Ranger-Moore J, Fang Q, Volkir P, Safaeian M, Ridder R. Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: results from the IMPACT trial. Int J Cancer. 2022;150(3):461\u201371.","journal-title":"Int J Cancer"},{"issue":"6","key":"2936_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cncy.21542","volume":"123","author":"C Bergeron","year":"2015","unstructured":"Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, et al. Prospective evaluation of p16\/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol. 2015;123(6):373\u201381.","journal-title":"Cancer Cytopathol"},{"issue":"20","key":"2936_CR27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","volume":"105","author":"H Ikenberg","year":"2013","unstructured":"Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, et al. Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013;105(20):1550\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2936_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/LGT.0000000000000802","volume":"28","author":"MA Clarke","year":"2024","unstructured":"Clarke MA, Wentzensen N, Perkins RB, Garcia F, Arrindell D, Chelmow D, Cheung LC, Darragh TM, Egemen D, Guido R, et al. Recommendations for use of p16\/Ki67 dual stain for management of individuals testing positive for human papillomavirus. J Low Genit Tract Dis. 2024;28(2):124\u201330.","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"2936_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.33320","volume":"148","author":"J Bonde","year":"2021","unstructured":"Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, Valencak AO, Pedersen H, Doorn S, Quint WG, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study. Int J Cancer. 2021;148(2):396\u2013405.","journal-title":"Int J Cancer"},{"issue":"1","key":"2936_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1186\/s12885-018-5125-8","volume":"18","author":"M Schmitz","year":"2018","unstructured":"Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, Tettenborn Z, Hansel A, Ikenberg H. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer. 2018;18(1):1197.","journal-title":"BMC Cancer"},{"key":"2936_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","volume":"9","author":"M Schmitz","year":"2017","unstructured":"Schmitz M, Wunsch K, Hoyer H, Scheungraber C, Runnebaum IB, Hansel A, Durst M. Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women. Clin Epigenetics. 2017;9:118.","journal-title":"Clin Epigenetics"},{"issue":"16","key":"2936_CR32","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.3390\/cancers14163954","volume":"14","author":"M Leffers","year":"2022","unstructured":"Leffers M, Herbst J, Kropidlowski J, Prieske K, Bohnen AL, Peine S, Jaeger A, Oliveira-Ferrer L, Goy Y, Schmalfeldt B, et al. Combined liquid biopsy methylation analysis of CADM1 and MAL in cervical Cancer patients. Cancers (Basel). 2022;14(16):3954.","journal-title":"Cancers (Basel)"},{"key":"2936_CR33","doi-asserted-by":"crossref","unstructured":"Li M, Zhao C, Zhang X, Li J, Zhao Y, Zhang W, Ren L, Wei L. PAX1\/JAM3 methylation and HPV viral load in women with persistent HPV infection. Cancers (Basel) 2024, 16(7).","DOI":"10.3390\/cancers16071430"},{"issue":"1","key":"2936_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-020-00885-7","volume":"12","author":"L Kong","year":"2020","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, Wu M, Liu P, Li L. DNA methylation for cervical cancer screening: a training set in China. Clin Epigenetics. 2020;12(1):91.","journal-title":"Clin Epigenetics"},{"issue":"28","key":"2936_CR35","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2217\/fon-2023-0226","volume":"19","author":"L Yang","year":"2023","unstructured":"Yang L, Tao H, Lin B, He X, Chen Y, Fan X. Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16\/18 high-risk HPV infection in women. Future Oncol. 2023;19(28):1917\u201327.","journal-title":"Future Oncol"},{"issue":"2 pt 2","key":"2936_CR36","first-page":"794","volume":"36","author":"H zur Hausen","year":"1976","unstructured":"zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res. 1976;36(2 pt 2):794.","journal-title":"Cancer Res"},{"issue":"2","key":"2936_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189\u201397.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2936_CR38","doi-asserted-by":"publisher","first-page":"10200","DOI":"10.1038\/s41598-017-09842-6","volume":"7","author":"M Di Paola","year":"2017","unstructured":"Di Paola M, Sani C, Clemente AM, Iossa A, Perissi E, Castronovo G, Tanturli M, Rivero D, Cozzolino F, Cavalieri D, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7(1):10200.","journal-title":"Sci Rep"},{"key":"2936_CR39","doi-asserted-by":"crossref","unstructured":"Feng G, Beilei Z, Caizhi C, Wen Z. Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database. Biosci Rep 2019, 39(12).","DOI":"10.1042\/BSR20192706"},{"issue":"1","key":"2936_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1186\/s12885-024-12658-z","volume":"24","author":"X Yang","year":"2024","unstructured":"Yang X, Zhou M, Luan Y, Li K, Wang Y, Yang X. Identification of key genes associated with cervical cancer based on bioinformatics analysis. BMC Cancer. 2024;24(1):897.","journal-title":"BMC Cancer"},{"issue":"1","key":"2936_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12885-018-4590-4","volume":"18","author":"B Pardini","year":"2018","unstructured":"Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer. 2018;18(1):696.","journal-title":"BMC Cancer"},{"issue":"5","key":"2936_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5468\/ogs.21123","volume":"64","author":"K Nagandla","year":"2021","unstructured":"Nagandla K, Lin KH, Chitra E, Jamli M. Role of MicroRNAs as biomarkers of cervical carcinogenesis: a systematic review. Obstet Gynecol Sci. 2021;64(5):419\u201336.","journal-title":"Obstet Gynecol Sci"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02936-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02936-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02936-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T10:02:41Z","timestamp":1750327361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02936-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2936"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02936-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1151"}}